Jeff Yass’s OptimizeRx OPRX Stock Holding History
Bought
Maintained
Sold
Other funds holding OPRX
MBAM
Jeff Yass's OPRX Position: Q3 2026 in Review
Jeff Yass increased its OptimizeRx (OPRX) stake by 200% in Q3 2026, buying an estimated $562K and bringing the position to 116,857 shares worth $976K. The position accounts for ﹤0.01% of the portfolio, ranked #7993.
Jeff Yass first reported a position in OPRX in Q4 2018 and has held it in 18 quarters since. The position peaked at $2.95M in Q1 2023. 103 funds tracked by Wall St. Rank hold OPRX as of Q3 2026.
- Jeff Yass held 116,857 shares of OptimizeRx worth $976K as of Q3 2026.
- Jeff Yass bought 77,854 OptimizeRx shares in Q3 2026, an estimated $562K.
- OptimizeRx made up ﹤0.01% of Jeff Yass's portfolio in Q3 2026, its #7993 holding.
- Jeff Yass first reported a position in OptimizeRx in Q4 2018 and has held it in 18 quarters since.
- Jeff Yass's OptimizeRx position peaked at $2.95M in Q1 2023.
- 103 funds tracked by Wall St. Rank held OptimizeRx as of Q3 2026.
Based on Susquehanna International Group's 13F filing for Q3 2026, filed 16 Nov 2026.